Ames Assay for Mutagenicity
The Ames test is designed to evaluate the potential of a test compound to induce reverse mutations in bacteria.
European Genetic Toxicology Workshop
Learn how to successfully execute genetic toxicology testing, satisfying regulatory criteria and smoothing your path to market in 's-Hertogenbosch, The Netherlands.
Ames Test Procedure
- Typically, four tester strains of Salmonella typhimurium (TA98, TA100, TA1535, and TA1537) and one strain of Escherichia coli (WP2 uvrA) are used in each assay.
- Others are available, including TA97a, TA102, and WP2 uvrA (pKM101).
- Each tester strain is incubated for two to three days with several dose levels of the test compound in the presence and absence of metabolic activation (S9).
- A positive outcome is characterized by a dose-dependent increase in revertant frequency that exceeds strain-specific limits.
Image of TA100 plate dosed with DMSO
When to Perform the Ames Test
- IND-enabling studies
- As part of the ICH S2(R1) standard battery (Option 1 or 2)
- REACH requirements
- As part of Annex VII testing
- Impurity assessment
- Required when an impurity, degradant or process intermediate has been identified as a possible mutagen during in silico analysis as per ICH M7 guideline